Botulinum toxin-A injections in children with neurogenic bladder
Authors
Abstract
Background: Botulinum-A toxin (BTX) administration appears to be useful in patients with high pressure neurogenic bladder.
Objectives: The aim of this study was to evaluate the usefulness of cystoscopic injections of BTX in the detrusor wall in the treatment of children with overactive neurogenic bladder dysfunctions.
Patients and Methods: The prospective, non-placebo controlled study was conducted with the approval of Local Ethics Committee. The study group consisted of 31 girls and 34 boys with neurogenic bladder overactivity, aged from 1 to 14 and treated with Botulinum-A toxin (Dysport, Ipsen).
Results: Both values of volumes of the catheterized urine and bladder volumes in urodynamic studies increased significantly after the therapy and it proved that the younger patient the more effective the percentage of volumes growth.
Conclusion: The results showed that endoscopic administration of BTX improved functional parameters of urinary bladder in cases of children with neurogenic bladder and the method might represent an alternative approach to operative reduction of intravesical pressures.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
Rohrsted M, Nordsten C, Bagi P. Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity. Nephro-Urol Mon. 2012;4(2):e93974. doi:
Treatment Failure of Botulinum Toxin A in Patients with Idiopathic Overactive Bladder: Why Do Patients Discontinue Treatment?
Marcelissen T, Rahnama’i MS, Brierley B, Schurch B, Vries PD. Treatment Failure of Botulinum Toxin A in Patients with Idiopathic Overactive Bladder: Why Do Patients Discontinue Treatment?. Nephro-Urol Mon. 2017;9(3):e46569. doi: https://doi.org/10.5812/numonthly.46569
Treatment Outcome of Neurogenic Bladder Dysfunction in Children; A Five-Year Experience
Roshanzamir F, Rouzrokh M, Mirshemirani A, Khaleghnejad A, Mohajerzadeh L, et al. Treatment Outcome of Neurogenic Bladder Dysfunction in Children; A Five-Year Experience. Inn J Pediatr. 2014;24(3):. doi:
Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children
Ashjaei B, Ahmadi J, Azary S, Paragomi P, Khalifeh-Soltani A. Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children. Inn J Pediatr. 2013;23(5):. doi:
The Effect of OnabotulinumtoxinA on the Symptoms and Quality of Life in Women with Urge Urinary Incontinence
Veisi F, Abdi H, Bayati M. The Effect of OnabotulinumtoxinA on the Symptoms and Quality of Life in Women with Urge Urinary Incontinence. J Clin Res Paramed Sci. 2021;10(2):e111274. doi: https://doi.org/10.5812/jcrps.111274
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 7
Last Update: 1 month ago
- Scopus by Title (Ref): 7
Last Update: 1 month ago
- CrossRef: 0
Last Update: 3 days ago